Approaches to the Treatment of Metastatic Prostate Cancer | Dr. Dan Petrylak
Yale Cancer Center Grand Rounds | March 3, 2026 Presented by: Dr. Daniel Petrylak
▶︎
Highlights from ASCO GU 2026: Treatment of Metastatic Hormone-Sensitive Prostate Cancer
▶︎
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
▶︎
Small Cell Lung Cancer: Updates, Progress, and Promise of 'Targeted Therapy' | Dr. Anne Chiang
▶︎
How I Live with Stage 4 Metastatic Prostate Cancer | Mark's Story | The Patient Story
▶︎
High-risk prostate cancer: what patients and physicians should know in 2026
▶︎
JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
▶︎
Metastatic Prostate Cancer: Treatment, Survival, and Quality of Life Explained
▶︎
Targeting the intersection between senescence and cancer
▶︎
Prostate Cancer Cure Explained: PSA, Recurrence, and Survival
▶︎
JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma
▶︎
New 2026 Guidelines: Mastering Prostate Cancer Treatment Sequencing
▶︎
Prostatakrebs: Neue Therapien, neue Perspektiven – Updates aus der Onkologie
▶︎
Doublet vs. Triplet Therapy for Newly Diagnosed Metastatic Prostate Cancer
▶︎
Webinar 6 - How metastatic prostate cancer is treated – Part 1
▶︎
Biochemical Recurrence in Prostate Cancer
▶︎
What’s Next in Type 1 Diabetes? Screening, Research Breakthroughs, and the Future of Care
▶︎
Newly Diagnosed Stage 4 #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
▶︎
HER2 Alterations in Lung Cancer: An Update | Dr John Heymach
▶︎
Prostate brachytherapy (seed implants) in 2026 explained for patients and physicians
▶︎